0001658021-20-000002.txt : 20201223 0001658021-20-000002.hdr.sgml : 20201223 20201223161437 ACCESSION NUMBER: 0001658021-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201223 EFFECTIVENESS DATE: 20201223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: General Oncology, Inc. CENTRAL INDEX KEY: 0001658021 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-343809 FILM NUMBER: 201412383 BUSINESS ADDRESS: STREET 1: 9 BRANDEIS ROAD CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-848-0924 MAIL ADDRESS: STREET 1: 9 BRANDEIS ROAD CITY: NEWTON STATE: MA ZIP: 02459 D/A 1 primary_doc.xml X0708 D/A LIVE 0001658021 General Oncology, Inc. 9 BRANDEIS ROAD NEWTON MA MASSACHUSETTS 02459 617-848-0924 DELAWARE None None Corporation true Gregg Goldstein c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Executive Officer Director Arnold Glazier c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Executive Officer Director Jeffrey Aaron Glazier c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Executive Officer Michael D. Sigman c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Director Michael J. Petit c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Director Pharmaceuticals Decline to Disclose 06b true 0001658021-20-000001 2019-06-25 true true false 0 2500000 1428750 1071250 false 19 0 0 0 false General Oncology, Inc. /s/ Gregg Goldstein Gregg Goldstein President 2020-12-23